Less than half of patients with malignant ureteral obstruction (MUO)—a serious complication of advanced cancer, with a poor prognosis—receive palliative care (PC) for their condition, reports a paper in the January issue ...
Dec 21, 2023
0
0
Despite their promise, immunotherapies fail to treat many cancers, including over 80% of some of the most advanced breast cancers. And many of those patients who do respond still experience metastases eventually. New research ...
Dec 20, 2023
0
175
QUT scientists have discovered a promising new therapy for a deadly type of endometrial cancer that has a poor prognosis if the cancer spreads or returns after initial treatment, a plight that affects 15%–20% of endometrial ...
Dec 13, 2023
0
0
A new study from researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborating organizations provides insight into the underlying mechanisms of gene mutations ...
Dec 9, 2023
0
0
A new Peter Mac study using a pioneering drug has successfully controlled the growth of tumors and overcome existing drug resistance in multiple cancer types.
Dec 7, 2023
0
0
Epigenetic changes can cause prostate cancer to resist treatment by switching genes on or off. One epigenetic mechanism tags genes with DNA methylation marks. This process is mediated by molecules called DNA methyltransferases. ...
Nov 15, 2023
0
0
An overwhelming majority of hepatocellular carcinoma occurs in people already suffering from cirrhosis of the liver.
Nov 14, 2023
0
0
One of the biggest challenges in biomedical research is finding a way to capture the complexity of the human body in laboratory-based techniques, to enable them to be investigated accurately. Now, researchers from Japan report ...
Nov 9, 2023
0
0
Professor Chai Hong Rim of the Department of Radiation Oncology, Korea University's Ansan Hospital, along with student Jungsue Lee and Sooyeon Kim of the College of Medicine, Korea University, proved the efficacy of active ...
Nov 2, 2023
0
0
Men with high-grade prostate cancer and low prostate-specific antigen (PSA) levels have a poor prognosis. The question remains as to whether the chemotherapy drug docetaxel, which increases survival in metastatic prostate ...
Nov 1, 2023
0
49
